Peptides and inhibitors target APN overexpressed in tumors, and prevent tumor cell growth and invasion12,13; drugs that bind to the active site of this protein have been developed to treat tumors and some are in clinical trials10. The gene discussed is ANPEP; the disease is neoplasm.